According to Innate Pharma 's latest financial reports the company's current revenue (TTM) is A$79.76 M. In 2022 the company made a revenue of A$79.76 M an increase over the revenue in the year 2021 that were of A$20.66 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.